| Net Cash Provided by (Used in) Operating Activities |
$10,685,772 |
USD |
-45% |
Q3 2024 |
Q3 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$35,399,806 |
USD |
3274628% |
Q3 2024 |
Q3 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$12,121,404 |
USD |
-541% |
Q3 2024 |
Q3 2024 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q3 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
113,037,414 |
shares |
14% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$51,279,029 |
USD |
798% |
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$54,611,867 |
USD |
1539% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Valuation Allowance |
$1,021,075 |
USD |
-98% |
Q3 2024 |
Q3 2024 |
| Depreciation |
$26,845 |
USD |
-63% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,458,605 |
USD |
-97% |
Q3 2024 |
Q3 2024 |
| Additional Paid in Capital |
$351,725,060 |
USD |
|
Q3 2024 |
Q3 2024 |